Okano M, Kawa K, Kimura H, Yachie A, Wakiguchi H, Maeda A, et al. Proposed guidelines for diagnosing chronic active Epstein–Barr virus infection. Am J Hematol. 2005;80(1):64–9.
Yamaguchi M, Ohta A, Tsunematsu T, Kasukawa R, Mizushima Y, Kashiwagi H, et al. Preliminary criteria for classification of adult Still’s disease. J Rheumatol. 1992;19(3):424–30.
Efthimiou P, Georgy S. Pathogenesis and management of adult-onset Still’s disease. Semin Arthritis Rheum. 2006;36(3):144–52.
Stephan JL, Zeller J, Hubert P, Herbelin C, Dayer JM, Prieur AM. Macrophage activation syndrome and rheumatic disease in childhood: a report of four new cases. Clin Exp Rheumatol. 1993;11(4):451–6.
Straus SE. The chronic mononucleosis syndrome. J Infect Dis. 1988;157(3):405–12.
Kimura H, Hoshino Y, Kanegane H, Tsuge I, Okamura T, Kawa K, et al. Clinical and virologic characteristics of chronic active Epstein–Barr virus infection. Blood. 2001;98(2):280–6.
Cohen JI. Epstein–Barr virus infection. N Engl J Med. 2000;343(7):481–92.
Lay JD, Tsao CJ, Chen JY, Kadin ME, Su IJ. Upregulation of tumor necrosis factor-alpha gene by Epstein–Barr virus and activation of macrophages in Epstein–Barr virus-infected T cells in the pathogenesis of hemophagocytic syndrome. J Clin Invest. 1997;100(8):1969–79.
Lu G, Xie ZD, Zhao SY, Ye LJ, Wu RH, Liu CY, et al. Clinical analysis and follow-up study of chronic active Epstein–Barr virus infection in 53 pediatric cases. Chin Med J (Engl). 2009;122(3):262–6.
Kimura H, Morishima T, Kanegane H, Ohga S, Hoshino Y, Maeda A, et al. Prognostic factors for chronic active Epstein–Barr virus infection. J Infect Dis. 2003;187(4):527–33.